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Abstract
Canonical Wnt signaling plays a rate-limiting role in regulating self-renewal and differentiation in mouse embryonic stem
cells (ESCs). We have previously shown that mutation in the Apc (adenomatous polyposis coli) tumor suppressor gene
constitutively activates Wnt signaling in ESCs and inhibits their capacity to differentiate towards ecto-, meso-, and
endodermal lineages. However, the underlying molecular and cellular mechanisms through which Wnt regulates lineage
differentiation in mouse ESCs remain to date largely unknown. To this aim, we have derived and studied the gene
expression profiles of several Apc-mutant ESC lines encoding for different levels of Wnt signaling activation. We found that
down-regulation of Tcf3, a member of the Tcf/Lef family and a key player in the control of self-renewal and pluripotency,
represents a specific and primary response to Wnt activation in ESCs. Accordingly, rescuing Tcf3 expression partially
restored the neural defects observed in Apc-mutant ESCs, suggesting that Tcf3 down-regulation is a necessary step towards
Wnt-mediated suppression of neural differentiation. We found that Tcf3 down-regulation in the context of constitutively
active Wnt signaling does not result from promoter DNA methylation but is likely to be caused by a plethora of mechanisms
at both the RNA and protein level as shown by the observed decrease in activating histone marks (H3K4me3 and H3-
acetylation) and the upregulation of miR-211, a novel Wnt-regulated microRNA that targets Tcf3 and attenuates early neural
differentiation in mouse ESCs. Our data show for the first time that Wnt signaling down-regulates Tcf3 expression, possibly
at both the transcriptional and post-transcriptional levels, and thus highlight a novel mechanism through which Wnt
signaling inhibits neuro-ectodermal lineage differentiation in mouse embryonic stem cells.
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Introduction
Embryonic stem cells (ESCs) are in vitro cultured cells derived
from the preimplantation-stage embryo, which possess unconfined
capacity for self-renewal and multi-lineage differentiation towards
different embryonic germ layers. Pluripotency and self-renewal are
two essential features of ESCs, which make them not only a very
robust and suitable model for stem cell research, but also a
promising source for regenerative medicine. Also, with the
emergence of induced pluripotent stem cells (iPS) technology,
understanding the basic mechanisms governing the embryonic
stem state becomes of great interest for safe clinical applications in
regenerative medicine and stem cell programming.
Among different signaling pathways, Wnt/b-catenin signaling
has been shown to play a major role in maintaining self-renewal as
well as in regulating ESCs differentiation [1,2,3,4,5,6]. The
canonical Wnt/b-catenin signaling pathway is controlled by
post-translational modifications of b-catenin leading to its differ-
ential protein stability and sub-cellular localization. In the absence
of active Wnt signaling, b-catenin is negatively regulated by the so-
called ‘‘destruction complex’’, consisting of the Apc and Axin
scaffolding proteins and the glycogen synthase and casein kinases
(GSK and CK1), resulting in proteolytic degradation and low
levels of cytoplasmic b-catenin. Ligand-mediated Wnt signaling
activation leads to nuclear translocation of b-catenin where it
binds to members of the Tcf/Lef family of transcriptional factors
thus modulating the expression of a broad spectrum of
downstream target genes [7,8,9].
In vertebrates, the Tcf/Lef family encompasses four functionally
specialized members including Tcf1 (also known as Tcf7), Tcf3
PLOS Genetics | www.plosgenetics.org 1 May 2013 | Volume 9 | Issue 5 | e1003424
(also known as Tcf7l1), Tcf4 (also known as Tcf7l2) and Lef1 [10].
Whereas Tcf1, Tcf4 and Lef1 are known to activate different Wnt
target genes in the context of active Wnt signaling, Tcf3 primarily
functions as a transcriptional repressor [5,11,12,13,14,15,16]. Tcf3
is the most abundant Tcf/Lef member in mouse ES cells [14] and
is an integral component of the core pluripotency circuit, co-
occupying Oct4, Nanog and Sox2 DNA binding sites
[17,18,19,20]. Loss of function experiments have shown that
Tcf3 down-regulation enhances self-renewal and confers differen-
tiation resistance in mouse ESCs [14,17,19,20,21,22]. In fact, both
the zebrafish headless/tcf3 mutant and the Xenopus embryo depleted
of TCF3 reveal anterior head defects resembling the Wnt-gain of
function phenotype [11,15,16]. Similarly, Tcf3 ablation in mice
resulted in expanded axial mesoderm and loss of anterior neural
tissues [21]. Tcf3 is ubiquitously expressed through the mouse
embryo at embryonic day 6.5 (E6.5) and is gradually localized in
the anterior part of the embryo at E7.5 and the anterior
neuroectoderm at E8.5 [23,24].
Although several studies have demonstrated the key role played
by Wnt signaling in regulating self-renewal and differentiation of
both mouse and human ESCs, the downstream effects through
which Wnt exerts these functions have been a matter of
controversy. To date, three models have been suggested in this
regard: a. Tcf-independent, b-catenin/Oct4 signaling [25]; b.
Tcf3 antagonism by nuclear b-catenin which relieves Tcf3
repression and enhances self-renewal. A minimal role for the
canonical Tcf/b-catenin signaling has been suggested in this
model [6]; and c. synergistic action of Tcf3 antagonism and the
canonical b-catenin/Tcf1 signaling [5]. Although these studies
have shed some light on the underlying mechanisms through
which Wnt signaling controls self-renewal, none of the above-
mentioned models explains how this signaling pathway regulates
the lineage differentiation potential of ESCs.
In order to elucidate the downstream effects of Wnt signaling on
lineage commitment and differentiation in embryonic stem cells,
we examined several Apc-mutant ESCs harboring different levels
of Wnt signaling and compared their gene expression profiles with
wild type ESCs. We show that activation of Wnt signaling down-
regulates Tcf3 expression in mouse ESCs. We provide evidence
that Tcf3 down-regulation represents a main downstream effect
through which Wnt signaling directs the differentiation of
pluripotent ESCs towards non-neuroectodermal lineages. More-
over, we show that Wnt-mediated repression of Tcf3 involves
epigenetic regulation associated with histone modifications and
Wnt-mediated induction of miR-211. Our data demonstrate that
Wnt signaling counteracts Tcf3 function at multiple levels, which
ultimately ensures the delicate balance between self-renewal and
differentiation in mouse ESCs.
Results
Lineage differentiation in Apc-mutant ESCs correlates
with the level of Wnt signaling
To attempt the elucidation of the mechanisms underlying
lineage differentiation in the context of Wnt activation, we have
derived several ES clones from pre-implantation blastocysts
carrying different hypomorphic Apc alleles: Apc1638T/1638T (ApcTT),
Apc1638N/1638T (ApcNT), Apc1638N/1638N (ApcNN) [26,27], together
with Apc+/+ as wild type controls. As previously reported, ApcTT,
ApcNT, and ApcNN encode for a gradient of different Wnt
signaling dosages [1,26], as also confirmed by TOP-Flash reporter
assay [28] with ApcNN showing the highest Wnt activity
(ApcNN&ApcNT.ApcTT.Apc+/+)(Figure 1A). The potential of
the Apc-mutant ES cells to differentiate into ecto-, meso- and
endodermal lineages was also evaluated and confirmed by the
teratoma formation assay followed by immunohistochemistry
(IHC) analysis, matching our previous results obtained with ES
clones obtained by two rounds of gene targeting by homologous
recombination [1]. As expected, no expression of neuroectodermal
markers (GFAP, SV2, and neurofilaments) was observed in
teratomas derived from ApcNN ES cells (Figure 1B).
ES cells can be cultured in serum-free medium supplemented
with LIF, GSK inhibitor (CHIRON) and Mek inhibitor (PD), the
so-called 2i medium [29]. Using the serum-free culture supple-
mented with a single inhibitor, we found that ApcNN cells have the
highest colony-forming capacity when cultured in LIF+Mek
inhibitor, suggesting that their constitutive Wnt signaling activity
replaces the need for additional pathway activation by the GSK
inhibitor (Figure 1C). Of note, culturing ApcNN ESCs in medium
supplemented with CHIRON reduced the colony formation
capacity of these cells suggesting that a very high dosage of Wnt
signaling can compromise the growth of ApcNN cells. We also
observed that ApcTT and ApcNT cells formed similar number of
colonies in different culture conditions independently of CHIRON
supplementation, possibly pointing to the Wnt-independent effects
of Apc mutations in these cells (Figure 1C).
Wnt signaling down-regulates Tcf3 expression in mouse
ESCs
To elucidate the molecular mechanisms underlying the altered
cell fate decision in Apc-mutant ES cells, genome-wide transcrip-
tional analysis was performed on the newly derived cells.
Unsupervised hierarchical clustering analysis showed that global
gene expression in ApcNN ESCs is already influenced before
differentiation is induced, resolving ApcNN from WT expression
profiles in different branches of the dendogram (Figure 1D).
Among the genes differentially expressed between ApcNN ES cells
and their wild type counterparts (Table S1), we found that, unlike
other pluripotency markers (e.g. Oct4, Nanog, and Sox2), Tcf3 was
specifically down-regulated in ApcNN ES cells, an observation
Author Summary
The future successes of regenerative medicine largely rely
on our knowledge of, and our capacity to manipulate, the
cellular and molecular mechanisms governing stem cell
differentiation. A growing body of evidence suggests that,
in mouse embryonic stem cells, canonical Wnt/b-catenin
signaling not only enhances self-renewal but also directs
the cell fate decision towards non-neuroectodermal
lineages. However, little is known about the mechanisms
underlying the differentiation defects caused by constitu-
tive active Wnt signaling. Using a set of Apc-mutant ESCs
harbouring different levels of Wnt signaling, we found
that, among others, down-regulation of Tcf3, a key
member of the pluripotency circuit, as well as induction
of a novel Wnt-regulated microRNA, miR-211, represent
two important downstream effects through which Wnt
signaling inhibits neural differentiation in mouse ESCs. We
also provide a more detailed picture on how Wnt signaling
counteracts Tcf3 function in stem cells by showing that
Tcf3 repression, in the context of active Wnt signaling,
involves histone modifications at the Tcf3 promoter and
the activation of miR-211, which post-transcriptionally
stabilizes Tcf3 downregulation. Understanding the down-
stream effects of Wnt signaling in ESCs is of both
fundamental and translational relevance, as it may be
exploited to manipulate ESC differentiation towards
specific cell lineages.
Wnt-Mediated Tcf3 Down-Regulation in Mouse ESCs
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which was further confirmed by qRT-PCR and western blot
analysis (Figure 2A and 2B; and Figure S1). Further qRT-PCR
analysis revealed that the observed downregulation is specific for
Tcf3 but not for other members of the Tcf/Lef family (Figure
S2A). Whereas Tcf3 was down-regulated in both ApcNN and
ApcMin/Min ESCs, the latter encode for the most severely truncated
Apc mutant allele and therefore for a very high level of Wnt
signaling, other members of the Tcf/Lef family were exclusively
up-regulated in ApcMin/Min ESCs.
Accordingly, Wnt activation achieved in wild type cells either by
Wnt3a conditioned medium or by a GSK3-small molecule
inhibitor (SB-216763), confirmed that Tcf3 down-regulation is a
specific response to canonical Wnt signaling in mouse ESCs
(Figure 2C, 2D, and 2E, and Figure S2B and S2C). Moreover,
using a gradient of the GSK inhibitor SB-216763, we observed
that unlike the canonical Wnt targets Axin2 and Cdx1, downreg-
ulation of Tcf3 required a higher Wnt signaling level, possibly
explaining why Tcf3 downregulation is observed in ApcNN cells
but not ApcTT or ApcNT ESCs (Figure 2F and Figure S1).
Rescuing Tcf3 expression in ApcNN ESCs partially restores
neural differentiation
It has been previously shown that Tcf3 not only functions as a
controller of self-renewal in wild type ESCs, but it is also required
for proper neurogenesis in zebrafish, xenopus and mice
[11,16,21]. We therefore hypothesized that Tcf3 down-regulation
in ApcNN ESCs might mediate the neural differentiation defects
observed in these cells. To test this hypothesis, we rescued Tcf3
expression by stably over-expressing its full-length cDNA in
ApcNN ES cells (Figure 3A, 3B). Tcf3 over-expression decreased
TOP-Flash reporter activity (Figure 3C) and, accordingly, reduced
the transcript levels of Cdx1 and Brachyury (T), two well-known Wnt
downstream targets. Gene expression profiling of Tcf3-expressing
ApcNN cells confirmed that Tcf3 effectively reverses the expression
pattern of several genes differentially expressed in ApcNN when
compared to wild type ESCs (Figure S3).
Since it has been previously reported that Tcf3 over-expression
in wild type ESCs induces differentiation under self-renewing
conditions [5], we first assessed whether over expressing Tcf3 in
ApcNN ESCs induces similar effects in these cells. As reported
above, ApcNN cells can grow in 1i medium (i.e. in LIF+Mek
inhibitor) in the absence of GSK inhibitor (Figure 1C). To
investigate whether Tcf3 can restore their dependency on the
GSK inhibitor in serum-free culture, Tcf3-over expressing ApcNN
cells were seeded at clonal density under different conditions and
subsequently stained for alkaline phosphatase (AP) to evaluate the
percentage of undifferentiated colonies. We found that, similar to
the parental ApcNN cells, Tcf3-rescued clones show the highest
Figure 1. Wnt signaling regulates the differentiation potential of mouse ESCs in a dosage-dependent manner. A. b-catenin/TCF
reporter assay in wild type and Apc-mutant ESCs. Measurements are reported as the average luciferase units performed in triplicate for the TOP (filled
bars) and FOP (empty bars) reporter constructs (data reported is mean6SD). Numbers in the histogram represent the calculated TOP/FOP ratios. B.
Table summarizing the results obtained by teratoma differentiation assay from different Apc-mutant ESCs and their wild type controls. Tissue sections
were stained with hematoxylin and eosin (H&E) or used in immunohistochemical analysis using specific antibodies against the neural markers: GFAP,
neurofilaments and synaptic vesicles. Adult myosin was used as a mesodermal marker to stain the striated muscle differentiation. Cartilage
differentiation was assessed either by H&E or theonin staining. Two independent clones were used for each genotype and differentiation was scored
as: (2) not present, (+) weakly present, and (++) present. C. Histogram showing the percent of colonies formed after plating 500 FACS-sorted cells in
N2B27 medium supplemented with different combinations of LIF, Mek inhibitor (PD) and GSK-inhibitor (CHIRON). Bars represent mean6 SD, n= 3. D.
Dendrogram derived from unsupervised hierarchical clustering of global gene expression in wild type, ApcTT, ApcNT and ApcNN ES cells. Pearson’s
correlation coefficient and Ward’s method were used after MAS 5.0 normalization of all probe sets.
doi:10.1371/journal.pgen.1003424.g001
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colony forming capacity in the presence of LIF and Mek inhibitor
(Figure 3D). Moreover, by applying the short term differentiation
assay in N2B27 medium, we found that both ApcNN and their
Tcf3-rescued counterparts retain expression of the pluripotency
markers Nanog while fail to express the early differentiation
markers Fgf5 (Figure 3E). Hence, constitutive Wnt signaling
prevents differentiation in a short-term assay despite the ectopic
Tcf3 expression.
We then asked whether rescuing Tcf3 expression in ApcNN cells
could affect the neural differentiation potential of these cells. To
this aim, we applied the in vitro neural differentiation assay
previously described by Bibel et al. [30]. We found that, whereas
wild type ESCs readily gave rise to Tuj1-positive cells, no staining
could be detected in ApcNN cells, while only few dispersed Tuj1-
expressing cells were observed in the Tcf3 rescued clones
(Figure 3F). In contrast, a clear increase in Nestin expression was
observed in Tcf3 over-expressing cells (Figure 3G and Figure S4).
This suggests that, although Tcf3 could not restore the formation
of fully mature Tuj1-proficient neurons, it does affect neural
differentiation in vitro in a more subtle fashion towards neural
Figure 2. Wnt signaling downregulates Tcf3 expression in mouse ESCs. A. qRT-PCR analysis of Tcf3 in wild type, ApcNN and ApcMin/Min ESCs.
Actb was used as an internal control; bars represent n = 2 6 SD. B. Western blot analysis of the core pluripotency markers Oct4, Nanog, Sox2 and Tcf3
on protein lysates isolated from two independent ApcNN clones and wild type control ESCs. Actb and Tubulin were used as an internal control. C–D.
qRT-PCR analysis of Tcf3 in wild type ESCs treated for different time intervals with Wnt3a conditioned medium (C), or with the GSK-inhibitor SB-
216763 (D). L-medium and DMSO were employed as controls, respectively. Actb was used as an internal control; bars represent n = 2 6 SD. E. Time
course western blot analysis of Tcf3 expression in wild type ESCs treated with Wnt3a conditioned medium (Wnt3a CM) or control L-medium (LM).
Actb was used as an internal control. F. qRT-PCR analysis of Tcf3 and Wnt target genes Axin2 and Cdx1 in wild type ESC treated for 48 h with different
concentrations of GSK-inhibitor SB-216763 or DMSO as control. Actb was used as an internal control; bars represent n = 2 6 SD.
doi:10.1371/journal.pgen.1003424.g002
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Figure 3. Characterization of Tcf3 over expressing ESCs. A–B. qRT-PCR (A) and western blot (B) analysis of Tcf3 in ApcNN ESCs stably
expressing Tcf3. Wild type and Tcf32/2 ESCs were used for comparison. Actb was used as an internal control. C. Histogram showing reduction of
b-catenin/Tcf reporter activity in ApcNN cells stably expressing Tcf3 (Tcf3 OE) compared to parental ApcNN cells and cells expressing the
corresponding empty vector. Luciferase signal from TOP or FOP reporter constructs were measured and TOP/FOP ratios are shown in the graph. Bars
represent n = 3 6 SD. D. Histogram showing the percent of alkaline phosphatase (AP) positive colonies formed by plating 500 FACS-sorted cells in
N2B27 medium after 7 days. N2B27 medium was supplemented with different combinations of LIF, PD and CHIRON. Two independent ApcNN ESC
clones (parental clone and transfected with empty vector) and three independent ApcNN ESC clones expressing Tcf3 (Tcf3 OE) were used. Bars
represent n= 3 6 SD. E. Histograms showing relative expression of the pluripotency markers Nanog and the early differentiation markers Fgf5 in
different ESCs cultured for 48 h in N2B27 medium. F. Confocal analysis of ES cells stained with Tuj-1-Alexa 488 and counterstained with the far-red
nuclear stain DRAQ5. Wild type, ApcNN and ApcNN expressing Tcf3 (Tcf3 OE) ESCs were used in 24/+4 neural differentiation assay and analyzed by
Wnt-Mediated Tcf3 Down-Regulation in Mouse ESCs
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progenitor-like cells. Next, we examined the differentiation
potential of Tcf3-rescued ES cells in vivo by teratoma assay. We
injected the newly generated clones into recipient isogenic mice to
generate teratomas and analyzed them for the expression of
different neuroectodermal markers by IHC. Interestingly, in
contrast to the control ApcNN teratomas which did not express
any neuroectodermal marker (0/20 analyzed teratomas), approx-
imately 50% of all teratomas generated from different Tcf3 over-
expressing ES clones were positive for the same set of markers (6/
10, 6/10, and 4/10 teratomas originated from clones 1, 2 and 3,
respectively)(Figure 4). However, the extent of neural differenti-
ation was lower compared to teratomas originated from wild type
ESCs. Unlike neuroectodermal lineages, Tcf3 did not rescue the
mesodermal cartilage-differentiation defect.
The observed difference in the results obtained by in vivo and in
vitro differentiation assay might reflect the presence of different
microenvironmental factors and the longer period of differentia-
tion in vivo, which result in a larger extent of neural differentiation
in teratomas.
Overall, these results indicate that Tcf3 expression in ApcNN
cells can partially rescue the neural differentiation defect
characteristic of these cells. Next, we then asked whether Tcf3
down-regulation in wild type embryonic stem cells is sufficient to
induce neural differentiation defects, characteristic of Wnt-high
ESCs. To this aim, teratomas were obtained by subcutaneous
transplantation of Tcf32/2 ESCs [14] followed by IHC and qRT-
PCR analysis of different neural markers. We observed reduced
neural differentiation in Tcf32/2 teratomas when compared to
wild type controls (Figure 5). However, high expression of the
pluripotency markers Oct4 and Nanog was also observed in Tcf32/2
teratomas (Figure 5). IHC analysis of Oct4 also showed that
Tcf32/2 teratomas are largely composed of undifferentiated,
embryonic carcinoma (EC) -like cells, confirming their undiffer-
entiated nature. This is in contrast with ApcNN teratomas where
pluripotency markers were down-regulated. These results suggest
that Tcf3 down-regulation in wild type ES cells is necessary but
insufficient to fully inhibit neural differentiation, and that
canonical Wnt signaling is still required for redirecting the
differentiation towards non-neuroectodermal lineages.
Tcf3 down-regulation in ApcNN ESCs is associated with
histone modifications
To elucidate the mechanisms underlying Wnt-driven repression
of Tcf3 expression, we first analyzed its promoter activity in ApcNN
and wild type ESCs to localize the responsible regulatory elements.
We employed luciferase reporter constructs containing a 6.7 kb
genomic fragment upstream of the mouse Tcf3 ATG translation
start site as well as a series of different deletion constructs spanning
4.5 kb, 3.5 kb, 2.2 kb, 1.2 kb and 176 bp fragments of the same
region (Figure S5A) [31]. The 4.5 kb fragment was previously
shown to resemble endogenous Tcf3 expression in mouse embryo
as well as embryonic derived neural stem cells [31]. To test
whether Wnt signaling affects Tcf3 promoter activity, we
transfected the different Tcf3 promoter constructs in ApcNN and
wild type ESCs. Likewise, transfected wild type ESCs were also
treated with Wnt3a conditioned medium or L-control medium to
examine Tcf3 promoter activity. Using both approaches, we found
that the Wnt-mediated repression of Tcf3 is not regulated by
elements located within the 6.7 kb promoter region (Figure S5A).
However, we cannot exclude the possibility that long-range
enhancer elements located outside the 6.7 kb promoter region
might still contribute to the observed Tcf3 repression in Wnt
context.
The mouse Tcf3 promoter contains a large CpG island
extending over exon 1, 2 and 3. This indicates that DNA
methylation may play a role in the regulation of Tcf3 expression
[32]. To test whether the observed Tcf3 down-regulation in ApcNN
ESCs results from DNA methylation, we employed the bisulfite-
conversion method followed by sequencing and methylation-
specific PCR to analyze the Tcf3 promoter in ApcNN cells and
compare its methylation pattern to wild type ESCs. As depicted in
Figure S5B, we found that similar to wild type ESCs, the Tcf3
promoter is unmethylated in ApcNN cells thus suggesting that
DNA methylation is unlikely to represent the mechanism
underlying Wnt-driven Tcf3 down-regulation in mouse ESCs.
Active and repressed promoters are thought to be associated
with histone marks, which reflect the gene expression status of the
corresponding genes. To test whether Tcf3 down-regulation in
ApcNN cells is regulated via chromatin modifications, we
performed chromatin immunoprecipitation (ChIP) to analyze
post-translational histone modifications associated with active and
repressed promoters. We studied the active-chromatin marks
H3K4me3 and H3-acetylation as well as the repressed-chromatin
marks H3K27me3 and H3K9me3 in the Tcf3 promoter and
compared the histone modification patterns between ApcNN and
wild type ESCs. The immunoprecipitated chromatin was then
assessed by qPCR analysis with a panel of specific primers
covering a region encompassed between 22 kb to +2 kb from the
transcription start site (TSS), as well as 20 kb of the gene body
within the Tcf3 locus. In accordance with the observed Tcf3
downregulation in ApcNN cells, we found a decrease in the
activating marks H3K4me3 and H3Ac and, to a lesser extent, a
slight increase in the repressive marks H3K27me3 and H3K9me3
(Figure 6). Similarly, 12 h treatment of wild type ESCs with
Wnt3a conditioned medium significantly reduced the H3Ac and
H3K4me3 activating marks but had no effect on the H3K27me3
and H3K9me3 repressing marks (Figure S6). These data
demonstrate a correlation between Tcf3 expression and histone
modifications in its promoter suggesting that Wnt signaling might
regulate Tcf3 expression through epigenetic mechanisms. How-
ever, the mediator of this regulation still remains elusive.
miR-211, a novel Wnt-regulated microRNA, targets Tcf3
and attenuates early neural differentiation in wild-type
ESCs
It has been previously shown that members of the core
pluripotency circuit are fine-tuned via microRNA-mediated
regulation in embryonic stem cells [33,34,35,36,37]. Therefore
we tested the idea whether Wnt-driven repression of Tcf3
expression might also be mediated, post-transcriptionally, by
Wnt-induced miRNAs. To this aim, we profiled the different Apc-
mutant ESCs for microRNA expression by using a miRNA array
immunofluorescence after 13 days of culture. G. Flow cytometric analysis showing expression of the neural progenitor marker Nestin in ApcNN ESCs
stably expressing Tcf3 (Tcf3 OE) and their control cells (parental ApcNN clone and ApcNN transfected with the corresponding empty vector) or wild
type ESCs. Cells were analyzed by the 24/+4 neural differentiation assay and stained with specific antibody against Nestin and Tuj1 after 13 days of
culture. Wild type (WT) ESCs are shown as control to indicate the Tuj1 positive population which is absent in other genotypes (0.1% in average in Tcf3
OE clones). Numbers in the graph represent the percent of Nestin-positive cells. For wild type ESCs the Nestin-positive populations before and after
excluding the mature neurons are shown. See also Figure S4 for defining different FACS gates.
doi:10.1371/journal.pgen.1003424.g003
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encompassing specific probes for all known mouse miRNAs [38]
(data not shown). Of the different candidate miRNAs induced
upon Wnt activation, mmu-miR-211 showed a Wnt dosage-
dependent up-regulation among the different Apc-mutant ESCs
(Figure 7A). Accordingly, activation of Wnt signaling in wild type
ESCs either by Wnt3a conditioned medium (CM) or by GSK3
inhibition, confirmed that miR-211 is a novel Wnt-regulated
microRNA in mouse embryonic stem cells (Figure 7B and 7C).
In silico analysis with three software packages, namely Miranda
[39], Targetscan [40] and PicTar [41], pointed to several potential
Figure 4. Rescue of Tcf3 expression in ApcNN ESCs partially restores in vivo neural differentiation. Teratoma samples were obtained
from wild type, ApcNN and ApcNN stably expressing Tcf3 (Tcf3 OE) ESCs. Tissue sections were stained by H&E, thionin (marker of cartilage
differentiation), and by IHC with specific antibodies against the neural differentiation markers GFAP, 2H3 (neurofilaments) and SV2 (synaptic vesicles).
Oct4 IHC analysis was used to asses the presence of undifferentiated EC-like cells in the teratomas.
doi:10.1371/journal.pgen.1003424.g004
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miR-211 target genes predicted by all three programs. To narrow
down the list of potential targets, qRT-PCR analysis was performed
on wild type ESCs compared with ApcNN (Figure S7A) as well as on
wild type ESCs treated with Wnt3a CM (Figure S7B). We excluded
those predicted targets that showed up-regulation upon Wnt
signaling. Based on these results Sox11, Sf3b1 and Tcf3 were
selected for further analysis. Several stable ESC clones were
generated which ectopically over-express miR-211 in an otherwise
Figure 5. Tcf3 downregulation in wild-type ES cells impairs but does not fully inhibit neural differentiation. A. Immunohistochemistry
analysis was used to evaluate the neural differentiation in teratoma samples derived from Tcf32/2 or their wild type control (GS1) ESCs.
Immunostaining with specific antibodies revealed retention of the pluripotency marker Oct4 and expression of the neural markers GFAP,
neurofilaments (2H3) and synaptic vesicles (SV2) in Tcf32/2 teratomas. Thionin staining was used to evaluate cartilage differentiation. B. RNAs were
isolated from different teratoma samples and analyzed by qRT-PCR for differentiation markers. Dot plots show normalized qRT-PCR values for the
neural markers Map2, b-III-Tubulin and GFAP and for the pluripotency markers Oct4 and Nanog among the different teratoma samples. Each dot
represents one sample.
doi:10.1371/journal.pgen.1003424.g005
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wild type background (Figure S7C). Western blot analysis showed
that, unlike Sox11 and Sf3b1 (Figure S7D), Tcf3 protein level was
decreased upon miR-211 ectopic expression (Figure 7D). To
confirm that miR-211 directly targets Tcf3, we cloned the 39
untranslated region (39UTR) of the mouse Tcf3 gene in the
pmirGLO reporter plasmid (Figure 7E) and performed a luciferase-
based reporter assay. Transfection of HEK293 cells with the Tcf3-
39UTR reporter plasmid confirmed that Tcf3 is a direct target of
miR-211 (Figure 7F). The inhibitory effects of miR-211 were not
observed when mutant forms of the 39UTR, i.e. lacking 7 or 4
nucleotides of the miRNA seed sequence target (MTR1 andMTR2
respectively) were used (Figure 7F).
We next assessed the differentiation potential of miR-211 over-
expressing clones using in vitro neural differentiation assay as well
as in vivo teratoma formation. FACS analysis for Tuj1, a marker for
mature neurons and Nestin, revealed that both miR-211 over-
expressing ES cells and their wild type controls give rise to similar
number of neurons and neural progenitor cells after 13 days of in
vitro differentiation, thus suggesting that miR-211 does not affect
terminal neural differentiation. As expected, ApcNN cells show a
dramatic reduction in mature, Tuj1-proficient neurons
(Figure 7G). Teratoma formation assay also confirmed that miR-
211 does not suffice to inhibit neural differentiation (data not
shown).
To evaluate the role of miR-211 at earlier stages of differen-
tiation, we derived embryoid bodies (EBs) from miR-211 over-
expressing cells and their wild type controls and analyzed lineage
differentiation at different time points. EBs derived from wild type
ES cells encompass differentiated lineages from the three germ
layers, thus providing an in vitro assay recapitulating the early steps
of embryonic development. qRT-PCR analysis for different
lineage-specific markers indicated that, unlike mesodermal,
endodermal and pluripotency markers (data not shown), early
neuroectodermal differentiation was specifically attenuated by
miR-211. We found that expression of the primitive ectoderm
marker Fgf5 and of the neural progenitor markers Nestin and Pax6
as well as the early neural differentiation marker Sfrp2 were
repressed at day 3 of EB formation. Notably, these effects could
not be detected at later time points (day 6, 9 or 12; data not
shown). Similar results were obtained at early time points (i.e. after
24 h) in N2B27 culture medium, previously described to induce
neural differentiation in mESCs [42] (Figure 7H and 7I). These
results suggest that miR-211 functions at early stages of neural
differentiation and its ectopic expression in wild type ES cells is not
sufficient to inhibit further neural commitment as differentiation
proceeds.
Altogether, our results indicate that miR-211, a novel Wnt-
regulated miRNA, can fine-tune Tcf3 expression and attenuate
early neural differentiation in wild type ESCs.
Discussion
The role of Wnt/b-catenin signaling in controlling self-renewal
and lineage differentiation in pluripotent embryonic stem cells has
Figure 6. Regulation of Tcf3 in ApcNN ESCs is associated with histone modifications. Schematic representation of mouse Tcf3 locus and
the different amplicons (P1–P8) analyzed by QPCR in chromatin immunoprecipitation experiment. Chromatin was isolated from ApcNN and wild type
ESCs and was immunoprecipitated with specific antibodies against the activating histone marks (H3K4me3 and H3Ac) and the repression histone
marks (H3k27me3 and H3K9me3). The input DNA (chromatin before immunoprecipitation) and immunoprecipitated DNA was quantified by QPCR
and using specific primers as described in materials and methods. Values from each amplicon were normalized to input chromatin and fold change
was calculated relative to the corresponding negative region (P1). Bars represent n = 26SD.
doi:10.1371/journal.pgen.1003424.g006
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Figure 7. The Wnt-regulated miR-211 targets Tcf3 in mouse ESCs. A. qRT-PCR analysis showing a dosage-dependent up-regulation of miR-
211 in different Apc-mutant ESCs. SnoRNA-234 was used as an internal control; bars represent n= 26SD. B–C. Time course analysis of wild type ESCs
treated with Wnt3a conditioned medium (B) or with the GSK-inhibitor SB-216763 (C). L-medium and DMSO were used as controls, respectively. RNAs
were isolated at different time points and were subjected to qRT-PCR analysis of miR-211 or snoRNA-234 as an internal control. Bars represent
n = 26SD. D. Western blot analysis of Tcf3 expression in protein lysates isolated from independent clones of wild type ESCs stably expressing miR-211
(miR-211 OE) or the corresponding empty vector (control). Two independent ApcNN clones were included for comparison. E. Schematic
representation of the Tcf3-39-UTR luciferase vector derived from the pmirGLO construct (Promega). Sequence alignment between miR-211 and its
target site on Tcf3-39-UTR. Site directed mutagenesis was used to introduce 7-bp or 4-bp mutations in Tcf3-39-UTR. F. HEK-293 cells were
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been a matter of controversy. Although both GSK3 inhibitors and
Wnt ligands are essential to support ESCs self-renewal, it is yet
unclear whether this occurs through b-catenin- and TCF-
dependent mechanisms [43]. Among the members of the Tcf/
Lef family of transcription factors, Tcf3 and Tcf1 are the most
abundant in ES cells. This is of relevance as, while Tcf1 appears to
function as a canonical transcriptional activator upon association
with b-catenin, Tcf3 acts as a b-catenin-independent transcrip-
tional repressor of self-renewal, suppressing genes such as Nanog,
Oct4 and other members of the core pluripotency circuitry [17,19].
In this scenario, it is yet unclear how canonical Wnt signaling
controls the balance between Tcf1- and Tcf3-mediated gene
activation and repression in the regulation of self-renewal and
differentiation in ESCs.
During the last few months, several studies have been published
on the specific roles of b-catenin and Tcf3 in these processes
[4,5,6,44]. In the classical Wnt model, Tcf factors bind DNA and
repress gene expression in the absence of active Wnt signaling.
Activating the signaling pathway leads to the binding of b-catenin
to Tcf proteins thus converting them from transcriptional
repressors to transcriptional activators. Among the four members
of Tcf/Lef family, Tcf3 seems to be different as its repressor
function is not directly affected by Wnt signaling. In this
perspective, two modes of action have been described for the
relief of Tcf3 repression by Wnt signaling: 1) Tcf3 phosphorylation
by homeodomain interacting protein kinase 2 (HIPK2) which is
mediated by b-catenin and results in displacement of Tcf3 from its
target sites [45]; and 2) direct physical interaction between b-
catenin and Tcf3 which displaces Tcf3 and inhibits its repressive
role in the context of active Wnt signaling [6,46]. Recently, using a
knock-in mouse model lacking the b-catenin-interaction domain of
Tcf3, Wu et al have demonstrated that counteracting Tcf3
function is not mediated by the physical interaction between b-
catenin and Tcf3 during the first stages of embryonic development
[47]. In view of these models, our data suggest that transcriptional
and post-transcriptional down-regulation of Tcf3 expression might
be yet another mechanism by which Wnt signaling inhibits Tcf3
function. It is worthwhile mentioning, however, that Wnt signaling
does not seem to fully suppress Tcf3 expression and that residual
levels of Tcf3 are retained even in the most severely truncated Apc
mutant alleles (i.e. ApcMin/Min ESCs; Figure 2A) which encode for
extremely high Wnt signaling dosages. Altogether these observa-
tions suggest that Wnt/b-catenin signaling regulates Tcf3 at
several levels and by a combination of multiple mechanisms
during different stages of embryonic development.
Although over-expression of a dominant negative form of Tcf1
or Tcf4 reduced the canonical Wnt reporter activity (TOP-Flash),
it failed to rescue the neural differentiation in GSK-null ESCs
[25]. Inhibition of b-catenin in GSK3b-null ESCs, however, was
sufficient to rescue the neural differentiation defect thus confirm-
ing the central role of b-catenin-dependent mechanisms in this
process [25]. The partial rescue of neural differentiation by Tcf3
expression in ApcNN cells, as shown here, highlights the distinct
role of Tcf3 from other members of the Tcf/Lef family and
suggests that a plethora of Tcf3-dependent and -independent
mechanisms underlie the Wnt-regulated lineage differentiation in
embryonic stem cells.
As for self-renewal maintenance in ES cells, Wray et al have
shown that a mutant form of b-catenin where the trans-activating
domain was deleted, can still maintain self-renewal in mESCs
cultured in 2i medium [6]. This suggests that maintenance of self-
renewal is mediated by Tcf3 displacement rather than b-catenin
signaling in 2i culture. Based on this, one can hypothesize that
forced overexpression of Tcf3 in Wnt context could restore the
dependency on CHIRON in serum-free culture. Our data show
that Tcf3 overexpression in ApcNN cells does not induce
differentiation in 2i culture, highlighting the dominant role of
Wnt signaling in this process. This is in line with the report by Yi
et al. which showed that over expressing Tcf3 in the context of
Wnt signaling activation has minimal effect on self-renewal
suggestive of a synergistic action of Tcf3 antagonism and b-
catenin/Tcf1 signaling [5].
In an attempt to elucidate the mechanisms underlying Tcf3
downregulation in the context of active Wnt signaling, we found
that Tcf3 down-regulation does not require DNA methylation but
is associated with alterations in histone marks at the core Tcf3
promoter region which are likely to regulate Tcf3 expression.
Notably, these modifications occur shortly after Wnt stimulation
and it is plausible to think that the chromatin modifications within
the Tcf3 locus can trigger the downregulation process of Tcf3
expression which can be stabilized further on via miR-211
function. Epigenetic regulation through histone modification or
DNA methylation was also shown previously for other antagonists
of Wnt signaling such as DACT3, sFRPs, WIF1 and DKK-1 in
different cancer cells [48,49,50,51]. Further experiments are
required to clarify whether this mode of gene repression is a
general mechanism for Wnt-induced gene silencing in embryonic
stem cells and tumor cells. Although the mediator of the observed
chromatin modifications downstream of Wnt signaling remains
elusive, we found that the putative cis-acting element, if any, is not
located in the 6.7 kb promoter region which was previously
described to regulate Tcf3 expression in different cell types [31].
Further work is needed to identify and study these cis-acting
elements which might be of potential interest for providing further
insight into the transcriptional repression downstream of Wnt
signaling.
As an additional regulatory mechanism, we also described a
novel Wnt-induced micro RNA, miR-211, and demonstrated that
it targets Tcf3 in ApcNN ESCs. However, miR-211 over-
expression in wild type ESCs does not reduce Tcf3 levels to the
same degree as observed in ApcNN ES cells thus suggesting that
multiple Wnt-mediated mechanisms are likely to exist. On the
other hand, microRNAs usually exert their function by targeting
multiple genes and it is plausible that miR-211 inhibits early
neural differentiation in mESCs by repressing target genes other
than Tcf3. Further experiments are required to characterize the
loss of miR-211 function phenotype in mouse ESCs in order to
evaluate the long-term effects on neural differentiation. The
co-transfected with the Tcf3-39-UTR luciferase vector, and either with miR-211 or a non-targeting miRNA. Luciferase activity was measured 24 h post-
transfection and normalized to Renilla luciferase signal. The same experiment was repeated with the mutant luciferase vectors, MTR1 and MTR2.
Asterix represent P-value,0.01 and bars represent n = 36SEM. G. Flow cytometric analysis of Tuj1 and Nestin in miR-211 over expressing ESCs (miR-
211 OE) and their controls (Emp) after 13 days of neural differentiation. Two independent clones were used for each genotype and representative
example of each genotype is shown. Numbers in the graph represent the percent of cells in neural (green), progenitor (red) or negative (blue)
populations. H. Histogram showing the relative expression of early neural markers Fgf5, Nestin, Pax6 and Sfrp2 in embryoid bodies derived from
independent wild type ESCs clones stably expressing miR-211 or the corresponding empty vector. RNAs were isolated at different time points and
were analyzed by qRT-PCR for different lineage markers. Bars represent n= 26SD. I. qRT-PCR analysis of Fgf5, Nestin, Pax6 and Sfrp2 in wild type ESCs
stably expressing miR-211 or the corresponding empty vector, cultured for 24 h in N2B27 medium. Bars represent n = 26SD.
doi:10.1371/journal.pgen.1003424.g007
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observation that Wnt signaling induces miR-211 expression might
also be of interest for other disciplines of research and in particular
cancer. In line with our observation, a tumor promoting function
has recently been described for miR-211 in colorectal cancer cells
[52]. Accordingly, miR-211 has also been shown to play a key role
in melanoma tumor formation and metastasis, as well as
mesenchymal to epithelial transition (MET) [53,54,55]
Taken together, we have revealed two downstream effects of
Wnt signaling which contribute to the differentiation defects
observed upon constitutive activation of canonical Wnt signaling,
namely downregulation of Tcf3 expression and induction of miR-
211. These cooperatively contribute to the inhibition of neural
differentiation previously observed in Apc-mutant mouse ESCs
[1]. We suggest that Wnt signaling represses Tcf3 expression
possibly by altering the histone marks at the Tcf3 promoter and
by activating miR-211 expression, thus extending our under-
standing of Tcf3 regulation in stem cells. In the future, additional
studies are required to elucidate how these mechanisms
contribute to the regulation of Tcf3 expression and, more in
general, how Wnt signaling regulates stemness in embryonic and
adult stem cells.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee on the Ethics of Animal
Experiments of the Erasmus Medical Center (DEC permit
numbers EMC 2351). All efforts were made to minimize suffering.
ES cell cultures and expression vectors
Apc1638N/+ and Apc1638T/+ animals, kept on an inbred C57Bl6/J
background, were bred to derive ES cells from pre-implantation
blastocyts according to previously described protocols [56]. Cells
were cultured on MEFs inactivated by Mitomycin-C (Sigma) in
Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco) supple-
mented with 10% fetal calf serum (FCS, Gibco), L-glutamine
(2 nM, Gibco), Na-Pyruvate (1 mM, Gibco), non essential amino
acids (0.1 mM each, Gibco), 2-mercaptoethanol (55 mM, Gibco)
and LIF (1000 U/ml, Milipore). Bruce 4 ESCs were purchased
from American Type Culture Collection (ATCC) and Tcf32/2
and their wild type control GS1 ESCs were obtained as previously
decribed [14]. To stimulate Wnt signaling in wild type ESCs, cells
were cultured on gelatin coated dishes and treated with Wnt3a-
conditioned medium (collected from L-cells expressing Wnt3a
plasmid) or L-control medium (collected from parental L-cells).
Conditioned media were diluted 1:1 with ES medium and added
to wild type ESCs for different time points. The Gsk-inhibitor SB-
216763 was purchased from Sigma, dissolved in DMSO and used
at 10 mM final concentration. DMSO was used as control in all
the experiments.
Stable clones over expressing mmu-miR-211 were generated by
transfecting Bruce4 wild type ESCs with miR-211 expressing
plasmid pEZX-MR01 (Genecopoeia), or the corresponding empty
vector. Several G418 resistant clones (200 mg/ml) were selected
and validated for miRNA expression. In order to generate Tcf3
over expressing ESCs, ApcNN ESCs were co-transfected with
pCAG-HA-Tcf3-IRES-EGFP (gift of Dr. Bing Lim, National
University of Singapore, Singapore,) and Hygromycin resistance
plasmid. Transfected ES cells were selected for Hygromycin
(150 mg/ml). GFP expression in resistant clones was employed for
validation purposes. Several independent clones were isolated and,
upon validation by qPCR and western blot analysis for Tcf3
expression, employed for subsequent experiments.
The Tcf3-39-UTR plasmid was obtained by PCR amplification
from mouse genomic DNA of a 565 bp fragment encompassing
the Tcf3-39-UTR inclusive of the miR-211 target site (forward
primer 59-AAATTGAGCTCTCCCCTTGCGCTGTGGTG-39;
reverse primer 59-AAAAACTCGAGGGTGGGGGAAGGGG-
CAGA-39). PCR products were digested with SacI and XhoI and
ligated into SacI and XhoI-cut pmirGlo plasmid (Promega). All
constructs were sequenced to verify their authenticity.
Microarray analysis
RNA was isolated using the RNeasy Mini Kit (QIAGEN) from
cells lysed directly on the plate; a DNase step on the column was
performed according to manufacturer’s instructions. RNA quality
was controlled by RNA 6000 Nano LabChip kit (Agilent
Technologies). RNA was labeled using the GeneChip One-Cycle
Target Labeling kit, hybridized to MOE430 2.0 arrays (Affyme-
trix) according to manufacturer’s instructions. For data analysis,
CEL files were uploaded and normalized using MAS 5.0
algorithm in Expression Console software (Affymetrix, Inc).
Expression analysis was performed using Partek Genomics Suite
6.5 ((Partek Inc., St. Louis, MO) and Excel 2010 (Microsoft). A
robust empirical method coupled with a validation step using
qRT-PCR was used to confirm the modulation of gene expressions
between different genotypes. A modulation of gene expression was
validated when the observed fold-change is $1.5 and correspond-
ing to none overlapping individual values, not present in the
background. The unsupervised hierarchical clustering was per-
formed after MAS 5.0 normalization, using Pearson’s dissimilarity
as distance measure and Ward’s method for linkage analysis.
DNA methylation analysis
ESCs were cultured on 0.1% gelatin-coated dishes without
MEFs for 2 passages and genomic DNA was isolated using
DNeasy Blood & Tissue Kit (Qiagen). 1 mg of genomic DNA was
used in bisulfite conversion reaction using EZ DNA Methylation
Kit (Zymo Research) according to the manufacturer’s instructions.
Converted DNA was amplified by PCR using specific primers
(Table S2) designed with Methyl Primer Express Software 1.0
(Applied Biosystems) or MethPrimer software [57].
The PCR amplification was carried out using KAPA2G Robust
HotStart Taq DNA polymerase (Kapa biosystems) and PCR
conditions were: 95uC for 3 min and 39 cycles of 95uC for 15 s, 57
or 53uC for 15 sec and 72uC for 15 sec, followed by 10 min at
72uC. PCR products from Region A, B and D were employed in
direct sequencing using ABI BigDye Terminator and ABI 31306l
genetic analyzer (Applied Biosystems).
Embryoid body formation
ESCs were trypsinized, re-suspended in ES medium and plated
on gelatin-coated culture dishes for 30 min to remove MEFs. Non-
attached ESCs were resuspended in EB medium (ESCs medium
without LIF) at a cell density of 26105 cells/ml and plated on a
non-adherent bacterial dish to initiate EB formation. EBs were
collected by centrifugation (800 rpm for 5 min) every three days
and re-suspended in fresh medium. 1/5 volume of EBs suspension
was used for RNA extraction while the remaining EBs were kept in
culture until day 12.
N2B27 short term differentiation
Differentiation assays were performed as previously described
[42]. Shortly, cells were trypsinized and plated on gelatine-coated
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dishes in N2B27 medium consisting of DMEM/F12:Neurobasal
medium (1:1, Gibco) supplemented with N2 and B27 (Gibco).
Cells were harvested after 24 h or 48 h of differentiation for
further analysis.
24/+4 neural differentiation assay
Neuronal differentiation of ESCs was induced as previously
described [30]. Briefly, ESCs were trypsinized and incubated in
ES medium on gelatine-coated dishes for 30 min. to allow
attachment of MEFs. Non attached cells were collected and
36106 cells were cultured in 10 cm. non-adherent bacterial dishes
(Greiner Bio-One) in EB medium for 8 days. Medium was
refreshed every 2 days and 5 mM all-trans retinoic acid (Sigma)
was added at day 4 and 6. On day 8 cells were trypsinized and
plated on poly-L-ornithine/laminin-coated dishes at a density of
26105 cells/cm2 in N2 medium. Poly-L-ornithine (Sigma) and
laminin (Roche) were used at final concentrations of 0.1 mg/ml
and 20 mg/ml, respectively.
N2 medium was refreshed after 2 and 24 hrs. from cell plating
to remove dead cells. The N2 medium consisted of: DMEM/F12
(Gibco) supplemented with L-glutamine (Gibco), Nonessential
amino acids (GIBCO), Insulin (25 ug/ml, Sigma), Progesterone
(20 nM, Sigma), Putrescine (100 nM, Sigma), Transferrin (50 mg/
ml, Sigma), Bovine serum albumin (50 mg/ml, Sigma), Sodium
selenite (30 nM, Sigma) and Penicillin-Sterptomycin (Gibco).
After 48 h from cell plating, medium was changed to N2B27
and refreshed every 2 days. Cells were collected after 5 days of
plating for further analysis.
Colony forming assay and alkaline phosphatase staining
Cells were trypsinized and plated on 0.1% gelatin-coated dishes
for 30 min to remove MEFs. 500 FACS sorted cells were plated on
each well of a gelatinized 24-well plate in N2B27 medium
supplemented with different combinations of CHIR99021 (3 mM,
Stemgent), PD0325901 (1 mM, Stemgent) and LIF (1000 U/ml,
Milipore). Total number of colonies were counted after 5 days
from plating upon staining with alkaline phosphatise (Milipore)
according to manufacture’s instructions.
Teratoma formation
Teratomas were obtained upon subcutaneous injection of
56106 cells (in PBS) into C57Bl6/J, for Apc-mutant ESCs (and
their wild type controls), and NOD/SCID, for Tcf32/2 ESCs (and
their wild type controls), recipient mice. Teratomas were collected
after 2–3 weeks and used for further experiments.
RNA isolation, cDNA synthesis, and qRT–PCR
RNA was isolated using Trizol (Invitrogen) or RNeasy Mini
Kit (QIAGEN) and treated with DNase (Ambion) to remove
contaminating genomic DNA. For gene expression analysis
cDNA was synthesized using 1 mg RNA and the RevertAid H
Minus First Strand cDNA Synthesis Kit (Thermo). microRNA
expression analysis was performed using 40 ng of total RNA
isolated by Trizol and employed in cDNA synthesis reaction
using TaqMan MicroRNA Reverse Transcription kit (ABI). Real-
time RT-PCR was performed using Applied Biosystems inven-
toried assays or TaqMan MicroRNA Assays on a 7900HT ABI
real-time PCR system (Applied Biosystems). The Delta-Ct
method was used to quantify the mRNA or miRNA relative
gene expressions. Actb or snoRNA234 were used for normalization,
respectively. qPCR analysis of the selected genes were performed
using Fast SYBR Green Master Mix (ABI) and the primers listed
in Table S2.
Immunohistochemistry
Isolated teratomas were fixed in PFA (4%) and embedded in
paraffin. Five mm sections were mounted on slides stained by H&E
for routine histology. Antibodies employed for IHC analysis
included: rabbit anti-GFAP (1:5000, Z0334, DAKO,); mouse 2H3
against Neurofilaments (1:50, Developmental Studies Hybridoma
Bank); mouse SV2 against Synaptic vesicles (1:50, Developmental
Studies Hybridoma Bank); mouse A4.1025 against Adult myosin
(1:50, Developmental Studies Hybridoma Bank); goat anti-Oct3/4
(1:100, sc-8629, Santa Cruz). Signal detection was performed
using HRP-conjugated Goat anti mouse (1:250, Jackson Immu-
noResearch), rabbit-anti-Goat-HRP (Dako) or Rabbit Envision kit
(Dako).
Immunofluorescence and confocal microscopy
Cells were harvested and fixed in 2% PFA for 20 min, washed
with PBS, and permeabilized with 0.1% triton X-100 in PBS for
15 minutes. Cells were then incubated in Blocking solution (PBS,
4% FCS) for 30 min., stained overnight at 4uC with the primary
antibody, washed and finally incubated with the secondary
antibody for 2 h. Confocal analysis was performed with a Zeiss
LSM510 confocal microscope. Tuj-1-Alexa488 was detected using
a 488 nm laser and BP 500–550 emission filter. DRAQ5 was
detected using a 633 nm laser and LP650 nm emission filter. Alexa
488-conjugated monoclonal anti-Tuj-1 was from Covance (A488-
435L) and was used at 1:4000 dilution.
Flow cytometry analysis
Flow cytometric analysis was performed with a BD FACSAria
III, using a yellow-green laser at 561 nm and a BP582/15
emission filter to detect anti-Nestin-PE antibodies, and 488 nm
laser and LP502 and BP530/30 emission filters for Tuj-Alexa-488
antibodies. A Live-Dead-Fixable red staining (Invitrogen) was
performed before fixation, to exclude dead cells and was detected
using a 633 nm laser and BP660/20 emission filter.
Alexa 488-conjugated anti-Tuj-1 antibody was used at a 1:4000
dilution and the mouse anti-nestin antibody was from BD (556309)
and was used at a 1:500 dilution together with a 2nd Rat-anti-
mouse PE-conjugated antibody (BD; 1:1000). DRAQ5 was from
Biostatus and was used as recommended by the manufacturer.
Luciferase reporter assays
For the b-catenin/TCF reporter assay, 56105 ES cells were
plated on 24-well plates seeded with MEFs and subsequently
transfected by Fugene HD (Roche) with 250 ng of the TOP-Flash
or FOP-Flash reporter constructs [28] together with 25 ng of the
Renilla luciferase vector for normalization purposes. Luciferase
activity was measured by Dual–Luciferase Reporter Assay System
(Promega). Tcf3 promoter activity was evaluated in ApcNN and
wild type ESCs similar to b-catenin/TCF reporter assay, as
mentioned above and by using Tcf3-promoter constructs (kindly
provided by Nina Solberg, SCI-CAST Innovation Center, Nor-
way) and pGL3 empty vector a control. To examine the effect of
Wnt3a treatment on Tcf3 promoter activity, cells were transfected
with luciferase constructs and treated with Wnt3a condition
medium or L-control medium for 48 h and luciferase activity was
measured using Dual–Luciferase Reporter Assay System (Pro-
mega).
For the 39UTR-Luciferase reporter assay, HEK293 cells were
plated in 24-well plates at a density of 0.56105 cells per well. Cells
were co-transfected with 250 ng of UTR (or MTR) reporter
plasmid and either mmu-miR-211 mimic or non-targetting
oligos (40 nM, Dharmacon) using lipofectamin 2000 (Invitrogen).
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Twenty-four hrs. after transfection, firefly-luciferase activity was
measured by Dual–Luciferase Reporter Assay System (Promega)
and normalized to the co-expressed Renilla luciferase signal.
Western blot analysis
ES cells were lysed using Cell Lysis Buffer (9803, Cell Signaling)
and a cocktail of protease inhibitors (11836170001, Roche).
Subsequently, NuPage LDS Sample Buffer (NP0008, Invitrogen)
and DTT (1 mM) were added. Primary antibodies employed in
western blot analysis included: Tcf3 (sc-8635, Santa Cruz); Sox2
(AF2018, R&D Systems); Sox11 (sc-20096, Santa Cruz); Oct4 (sc-
5279, Santa Cruz); Dyrk1A G-19 (G2905, Santa Cruz); Sap155/
Sf3b1 (D138-3, MBL); Nanog (AB5731, Milipore); b-actin (A5441,
Sigma); b-tubulin (ab6046, Abcam). Lysates were loaded on 10%
SDS-PAGE (BIO-RAD System), and transferred onto Immobilon-
FL PVDF membrane (IPFL00010, Millipore). Blocking was
performed at room temperature using LI-COR Blocking buffer
(Part#927-40000) diluted 1:1 with PBS. Incubation with the first
antibody was performed overnight at 4uC. Blots were subsequently
incubated with fluorescent-labeled secondary antibodies for
30 min. at room temperature. Goat anti-mouse IgG – IRDye
680 (1:5000, LI-COR Biosiences), Goat anti-rabbit IgG – IRDye
800CW (1:5000, LI-COR Biosiences) and Donkey anti-goat-
IRDye 800CW (1:5000, LI-COR Biosiences) were used as
secondary antibodies. Fluorescent signal was detected using LI-
COR scanner (LI-COR Biosiences).
Site-directed mutagenesis
Two mutant forms of the Tcf3-39UTR-luc plasmid were
generated using QuikChange Lightning Site-Directed Mutagene-
sis Kit (Agilent, 210518). We introduced either 7 bp substitutions
in the miRNA binding site (AAAGGGA into CCCTTTC) to
generate the MTR1-Luc plasmid, or 4 bp (AAAGGGA into
cAcGtGc) to generate the MTR2-Luc plasmid. The following
mutagenesis primers were employed in the reaction:
For MTR1, sense primer is 59-tctgaaatggtccccccccctgcatttccctttcct-
caaggtgcctaccactgccttc-39 and antisense primer is 59-gaaggcagtgg-
taggcaccttgaggaaagggaaatgcagggggggggaccatttcaga-39. For MTR2
plasmid the sense primer is 59-gtccccccccctgcatttcacgtgcctcaaggtgcc-
tacc-39 and the antisense primer is 59-ggtaggcaccttgaggcacgtgaaatg-
cagggggggggac-39.
The mutagenesis reaction was performed according to manu-
facture’s instruction. Briefly, mutant strands were synthesized
using the described primers followed by DpnI digestion of the
amplification products to remove the parental methylated strands.
Digestion reactions were transformed in XL10-Gold Ultracom-
petent cells and bacterial clones with correct nucleotide substitu-
tions were used for further plasmid extraction.
Chromatin immunoprecipitation (ChIP)
ChIP was performed on wild type and ApcNN ESCs or on wild
type ESCs treated for 12 h with Wnt3a conditioned medium or L-
control medium (1:1 dilluted with ES medium). Briefly, cells were
fixed in 1% PFA for 30 minutes at room temperature and PFA
was quenched afterwards with 125 mM glycine. Cells were
washed with buffer B (0.25% Triton-X 100, 1 mM EDTA,
0.5 mM EGTA, 20 mM Hepes, pH 7.6), buffer C (150 mM
NaCl, 1 mM EDTA, 0.5 mM EGTA, 20 mM Hepes, pH 7.6).
Cells were then sonicated in ChIP incubation buffer (0.3% SDS,
1% Triton-X 100, 0.15 M NaCl, 1 mM EDTA, 0.5 mM EGTA,
20 mM Hepes, pH 7.6) using a BioRuptor sonicator (Cosmo Bio
Co., Ltd) to obtain DNA fragments 200–700 base pairs.
Chromatin was diluted in ChIP dilution buffer (with 0.15%
SDS) and incubated with BSA-blocked protein-A/G Sepharose
beads (Amersham) and 5 mg antibody overnight at 4uC. Antibod-
ies used in this study include: H3K4me3 (Abcam, Ab8580-50),
H3K27me3 (Upstate, 07-449), H3K9me3 (Abcam, Ab8898-100),
H3Ac (Millipore #06-599)
Beads were washed with buffer 1 (0.1% SDS, 0.1% deoxycho-
late, 1% Triton-X 100, 150 mM NaCl, 1 mM EDTA, 0.5 mM
EGTA, 20 mM Hepes pH 7.6), buffer 2 (0.1% SDS, 0.1%
deoxycholate, 1% Triton-X 100, 0.5 M NaCl, 1 mM EDTA,
0.5 mM EGTA, 20 mM Hepes pH 7.6), buffer 3 (250 mM LiCl,
0.5% deoxycholate, 0.5% NP-40, 1 mM EDTA, 0.5 mM EGTA,
20 mM Hepes, pH 7.6), and buffer 4 (1 mM EDTA, 0.5 mM
EGTA, 20 mM Hepes, pH 7.6). Chromatin was eluted for 30 min
at room temperature in elution buffer (1% SDS, 0.1 M NaHCO3)
and together with input chromatin, decrosslinked overnight at
65uC in the presence of 200 mM NaCl. DNA was extracted using
QIAquick PCR Purification Kit and was used in QPCR analysis
using Fast SYBR Green Master Mix (ABI) and primers indicated
in Table S2.
Supporting Information
Figure S1 qRT-PCR validation of microarray results. Selected
differentially expressed genes include Wnt and pluripotency-
related genes. Measurements were performed in duplicates and
using two independent cell lines per genotype. Actb was used for
normalization. Plots represent average 6 SD of normalized qRT-
PCR values for two independent clones of each genotype.
(TIF)
Figure S2 A. Histogram showing relative expression of Axin2
and of members of the Tcf/Lef family in wild type, ApcNN and
ApcMin/Min ESCs. Actb was used for normalization. Bars represent
n = 26SD. B–C. qRT-PCR analysis of Axin2 and of members of
the Tcf/Lef family in wild type ESCs treated for different time
intervals with Wnt3a conditioned medium (B) and with the GSK
inhibitor SB-216763 (C). L-medium and DMSO were used as
control media. Actb was used for normalization. Bars represent
n = 26SD.
(TIF)
Figure S3 Heat map showing the results of the qRT-PCR
validation of microarray data relative to selected genes. Genes
differentially expressed between ApcNN and wild type ESCs were
compared to the list of genes differentially expressed between
ApcNN and Tcf3OE cells (Table S3). Among several genes
overlapping between the two microarray studies, 15 were selected
for QPCR validation. The heat map shows the fold change values
obtained from the microarray (M) and qRT-PCR (Q) data.
ApcNN/WT values represent the average fold change of 2 ApcNN
versus 2 WT ES clones for each gene. Tcf3 OE/ApcNN values
represent the average fold change of three Tcf3 OE versus three
ApcNN clones (parental cells as well as empty vector transfected
cells) for each gene. Scale represents log2 values.
(TIF)
Figure S4 Supporting data to Figure 3. Flow cytometric analysis
of wild type (WT) ESCs cells stained with isotype controls or
Nestin and Tuj1 specific antibodies. The double staining allows
the identification of Nestin positive neural progenitors and Nestin-
negative/Tuj-positive mature neurons (highlighted in green). The
left panel shows the Nestin-PE versus Tuj1 and the right panel
indicate the Nestin-PE against forward scattering (FSC) of the
same sample. Since Tcf3 over expressing clones gave rise to 0.1%
mature neurons in average, the Nestin-PE versus FSC has been
used in Figure 3.
(TIF)
Wnt-Mediated Tcf3 Down-Regulation in Mouse ESCs
PLOS Genetics | www.plosgenetics.org 14 May 2013 | Volume 9 | Issue 5 | e1003424
Figure S5 A. Tcf3 promoter activity in Wnt high and Wnt low
ESCs. Luciferase constructs containing different Tcf3 promoter
fragments were co-transfected with Renilla luciferase and the
relative promoter activity is shown after normalization to Renilla-
luciferase values. To monitor the effect of Wnt signaling on Tcf3
promoter activity, luciferase constructs were transfected in wild
type ESCs, followed by 24 h treatment with Wnt3a-condition
medium (Wnt3a) or L-control medium (LM). Similarly, luciferase
constructs were transfected in 2 independent clones of ApcNN or
wild type ESCs and promoter activity was measured after 48 h of
transfection. The genomic location of different Tcf3 promoter
fragments is depicted in the scheme. Bars represent n= 26SD. B.
DNA methylation analysis of Tcf3 promoter. Schematic repre-
sentation of the mouse Tcf3 promoter defined by the 59UTR and
,2 kb large CpG island extending into exons 1–3. For the
purpose of methylation analysis, the CpG island was subdivided
into regions A, B, C and D. Genomic DNA was first bisulfite-
converted and the individual regions either employed in bisulfite-
specific PCR followed by DNA sequencing (region A, B and D), or
used in methylation-specific PCR assays (region C). Arrows
represent methylated (and un-methylated) specific primers for
region C. PCR products from regions A, B and D were obtained
from ApcNN, wild type and ApcN/+ (Apc1638N/+) ESCs and directly
sequenced. ApcN/+ ESCs were employed as controls since they
express similar Tcf3 levels compared to wild type ESCs (data not
shown). The sequencing results are depicted as open and solid
circles for unmethylated and methylated CpG dinucleotides,
respectively. Dashed circles represent CpGs which were not
included in the PCR products. Because of its extremely GC-rich
sequence, PCR amplification of region C was carried out using
methylated- and unmethylated-specific primers (MSP and USP)
covering 4 different CpG dinucleotides. Control DNA (mouse
genomic DNA where all CpGs sites are enzymatically methylated
by means of CpG Methylase) was used in all bisulfite reactions as a
positive control.
(TIF)
Figure S6 Transient activation of Wnt signaling in wild type
ESCs reduces H3Ac and H3K4me3 activating marks in Tcf3
promoter. Bruce 4 wild type ESCs were cultured on gelatin-coated
dishes and treated with Wnt3a condition medium or L-control
medium for 12 h. Cells were used for ChIP-QPCR as described
before. Values from each amplicon were normalized to input
chromatin. Since no amplification was detected at the negative
region (P1) from some of the immunoprecipitated chromatin,
values are shown as percent of input DNA. Bars represent
n = 26SD.
(TIF)
Figure S7 A. Histogram showing relative expression of selected
miR-211 predicted targets in ApcNN and wild type ESCs. Two
independent clones were used for each genotype. Actb was used for
normalization. Bars represent n= 26SD. B. Histogram showing
relative expression of selected miR-211 predicted targets in wild
type ESCs treated with Wnt3a condition medium or L-medium
for different time intervals. The ratios of Wnt3a CM/L-medium
are shown in the graphs. Bars represent n = 26SD. C. qRT-PCR
analysis of miR-211 expression in wild type ESCs stably expressing
miR-211 or the corresponding empty vector. Two independent
ApcNN ESC clones were included for comparison. snoRNA-234
was used for normalization.Bars represent n= 26SD. D. Western
blot analysis of the miR-211 predicted targets Sox11 and Sf3b1 in
miR-211 over expressing cells and their wild type controls.
(TIF)
Table S1 Differentially expressed genes between WT, ApcTT,
ApcNT and ApcNN ESCs.
(ZIP)
Table S2 Primer sequences used in QPCR and DNA methyl-
ation analysis
(XLS)
Table S3 Differentially expressed genes between ApcNN and
ApcNN-over expressing Tcf3 (Tcf3 OE) ESCs.
(XLS)
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